US equities
|
GOOGL
$286.98
▼-11.67%
GOOG
$285.03
▼-11.45%
MSFT
$523.40
▼-1.43%
MU
$950.37
▼-3.34%
META
$628.84
▲+2.67%
AMZN
$248.29
▼-2.48%
NVDA
$213.98
▼-0.65%
AAPL
$348.82
▲+1.45%
GOOGL
$286.98
▼-11.67%
GOOG
$285.03
▼-11.45%
MSFT
$523.40
▼-1.43%
MU
$950.37
▼-3.34%
META
$628.84
▲+2.67%
AMZN
$248.29
▼-2.48%
NVDA
$213.98
▼-0.65%
AAPL
$348.82
▲+1.45%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Inari Medical, Inc. - Common Stock
(NQ:
NARI
)
79.97
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inari Medical, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 11, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
April 02, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
↗
March 30, 2024
Join the "Rule Breaker Investing" fun.
Via
The Motley Fool
Forecasting The Future: 7 Analyst Projections For Inari Medical
↗
March 22, 2024
Via
Benzinga
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
NEW YORK, NY - (NewMediaWire) - March 20, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
NEW YORK, NY - (NewMediaWire) - March 19, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 18, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 18, 2024
NEW YORK, NY - (NewMediaWire) - March 18, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 17, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 17, 2024
NEW YORK, NY - (NewMediaWire) - March 17, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
March 16, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
March 16, 2024
NEW YORK, NY - (NewMediaWire) - March 16, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
March 15, 2024
NEW YORK, NY - (NewMediaWire) - March 15, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
March 15, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
March 14, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
March 14, 2024
NEW YORK, NY - (NewMediaWire) - March 14, 2024 - Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Inari Medical, Inc. (“Inari Medical” or the “Company”)...
Via
TheNewswire.com
Topics
Regulatory Compliance
Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm
March 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry
March 12, 2024
Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials
From
Inari Medical, Inc.
Via
GlobeNewswire
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 11, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
NARI NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 09, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
NARI NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 09, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 09, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Bragar Eagel & Squire, P.C. Is Investigating Thoughtworks, Chemours, Methanex, and Inari Medical and Encourages Investors to Contact the Firm
March 08, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
NARI LOSS ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 07, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
NARI LOSS ALERT: ROSEN, A RESPECTED AND LEADING FIRM, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 07, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 07, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
Glancy Prongay & Murray LLP
Via
Business Wire
NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 06, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Regulatory Compliance
NARI INVESTOR NOTICE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Inari Medical, Inc. Investors to Inquire About Securities Class Action Investigation - NARI
March 06, 2024
WHY: NEW YORK, NY - (NewMediaWire) - March 06, 2024 - Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Inari Medical,...
Via
TheNewswire.com
Topics
Regulatory Compliance
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Inari Medical, Inc. (NARI) on Behalf of Investors
March 06, 2024
From
Law Offices of Howard G. Smith
Via
Business Wire
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
